PIP
MEDP icon

Palisades Investment Partners’s Medpace MEDP Stock Holding History

Palisades Investment Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Sell
2,216
-14,297
-87% -$6.6M 0.33% 48
2026
Q1 		$7.93M Buy
16,513
+239
+1% +$122K 3.11% 8
2025
Q4 		$9.14M Buy
16,274
+382
+2% +$217K 3.45% 6
2025
Q3 		$8.17M Buy
15,892
+135
+0.9% +$58.9K 3.21% 8
2025
Q2 		$4.95M Sell
15,757
-417
-3% -$125K 2.16% 19
2025
Q1 		$4.93M Buy
16,174
+255
+2% +$85.8K 2.47% 17
2024
Q4 		$5.29M Buy
15,919
+1,338
+9% +$454K 2.23% 18
2024
Q3 		$4.87M Buy
14,581
+889
+6% +$338K 2.12% 16
2024
Q2 		$5.64M Buy
+13,692
New +$5.42M 2.79% 13

Other funds holding MEDP

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Palisades Investment Partners's MEDP Position: Q2 2026 in Review

Palisades Investment Partners reduced its Medpace (MEDP) stake by 87% in Q2 2026, selling an estimated $6.6M and leaving 2,216 shares worth $1.17M. The position accounts for 0.33% of the portfolio, ranked #48.

Palisades Investment Partners first reported a position in MEDP in Q2 2024 and has held it in 9 quarters since. The position peaked at $9.14M in Q4 2025. 268 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Palisades Investment Partners held 2,216 shares of Medpace worth $1.17M as of Q2 2026.
  • Palisades Investment Partners sold 14,297 Medpace shares in Q2 2026, an estimated $6.6M.
  • Medpace made up 0.33% of Palisades Investment Partners's portfolio in Q2 2026, its #48 holding.
  • Palisades Investment Partners first reported a position in Medpace in Q2 2024 and has held it in 9 quarters since.
  • Palisades Investment Partners's Medpace position peaked at $9.14M in Q4 2025.
  • 268 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Palisades Investment Partners's 13F filing for Q2 2026, filed 4 Aug 2026.